Colorectal cancer is one of the most prevalent forms of cancer worldwide, and a previous study demonstrated that LBP treatment (at concentrations of 250 and 500 μg/mL) reduced the expression of the NLRP3 inflammasome and its associated protein PYCARD while also inhibiting the secretion of inflammatory cytokines (Lian et al., 2023). The gene discussed is LBP; the disease is cancer.